Raffa Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Raffa Wealth Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$582	Hold	23	–	–	﹤0.01%	1165
2026 Q1	$512	Buy	23 +1	+5%	+$24	﹤0.01%	1066
2025 Q4	$588	Hold	22	–	–	﹤0.01%	1047
2025 Q3	$469	Hold	22	–	–	﹤0.01%	1082
2025 Q2	$475	Hold	22	–	–	﹤0.01%	1007
2025 Q1	$365	Hold	22	–	–	﹤0.01%	999
2024 Q4	$404	Hold	22	–	–	﹤0.01%	1030
2024 Q3	$338	Hold	22	–	–	﹤0.01%	1021
2024 Q2	$358	Hold	22	–	–	﹤0.01%	1086
2024 Q1	$407	Hold	22	–	–	﹤0.01%	1062
2023 Q4	$689	Hold	22	–	–	﹤0.01%	919
2023 Q3	$458	Hold	22	–	–	﹤0.01%	963
2023 Q2	$527	Hold	22	–	–	﹤0.01%	960
2023 Q1	$414	Hold	22	–	–	﹤0.01%	991
2022 Q4	$350	Hold	22	–	–	﹤0.01%	991
2022 Q3	$360	Hold	22	–	–	﹤0.01%	1090
2022 Q2	$310	Hold	22	–	–	﹤0.01%	1079
2022 Q1	$533	Hold	22	–	–	﹤0.01%	1036
2021 Q4	$513	Hold	22	–	–	﹤0.01%	1043
2021 Q3	$365	Hold	22	–	–	﹤0.01%	1079
2021 Q2	$537	Hold	22	–	–	﹤0.01%	1031
2021 Q1	$568	Hold	22	–	–	﹤0.01%	1022
2020 Q4	$1.18K	Hold	22	–	–	﹤0.01%	703
2020 Q3	$908	Hold	22	–	–	﹤0.01%	695
2020 Q2	$1.07K	Buy	+22	New	+$1.06K	﹤0.01%	646
2018 Q4	–	Sell	-66	Closed	-$1.37K	–	742
2018 Q3	$1.37K	Hold	66	–	–	﹤0.01%	470
2018 Q2	$1.01K	Buy	+66	New	+$1.18K	﹤0.01%	576
2016 Q4	–	Sell	-15	Closed	-$477	–	883
2016 Q3	$477	Hold	15	–	–	﹤0.01%	747
2016 Q2	$487	Hold	15	–	–	﹤0.01%	702
2016 Q1	$419	Hold	15	–	–	﹤0.01%	745
2015 Q4	$535	Hold	15	–	–	﹤0.01%	665
2015 Q3	$496	Buy	+15	New	+$624	﹤0.01%	677

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Raffa Wealth Management's ACAD Position: Q2 2026 in Review

Raffa Wealth Management held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 23 shares worth $582. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Raffa Wealth Management first reported a position in ACAD in Q3 2015 and has held it in 32 quarters since. The position peaked at $1.37K in Q3 2018. 328 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Raffa Wealth Management held 23 shares of Acadia Pharmaceuticals worth $582 as of Q2 2026.
Raffa Wealth Management left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1165 holding.
Raffa Wealth Management first reported a position in Acadia Pharmaceuticals in Q3 2015 and has held it in 32 quarters since.
Raffa Wealth Management's Acadia Pharmaceuticals position peaked at $1.37K in Q3 2018.
328 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.